vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and CORVEL CORP (CRVL). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $235.6M, roughly 1.1× CORVEL CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 10.3%, a 4.6% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs 3.4%). CORVEL CORP produced more free cash flow last quarter ($35.2M vs $33.8M). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs 6.6%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Corvel Corp is a U.S.-headquartered provider of integrated workers’ compensation, healthcare management, and risk mitigation solutions. It serves insurance carriers, self-insured employers, and public sector clients, delivering services to control healthcare costs, improve care outcomes, and optimize administrative operations.
BCPC vs CRVL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $235.6M |
| Net Profit | $40.3M | $24.2M |
| Gross Margin | — | 23.3% |
| Operating Margin | 20.5% | 13.7% |
| Net Margin | 14.9% | 10.3% |
| Revenue YoY | 8.1% | 3.4% |
| Net Profit YoY | 8.7% | 1.7% |
| EPS (diluted) | $1.25 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $235.6M | ||
| Q3 25 | $267.6M | $239.6M | ||
| Q2 25 | $255.5M | $234.7M | ||
| Q1 25 | $250.5M | $231.5M | ||
| Q4 24 | $240.0M | $228.0M | ||
| Q3 24 | $239.9M | $224.4M | ||
| Q2 24 | $234.1M | $211.7M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $24.2M | ||
| Q3 25 | $40.3M | $27.9M | ||
| Q2 25 | $38.3M | $27.2M | ||
| Q1 25 | $37.1M | $26.4M | ||
| Q4 24 | $33.6M | $23.8M | ||
| Q3 24 | $33.8M | $23.4M | ||
| Q2 24 | $32.1M | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | 23.3% | ||
| Q3 25 | 35.7% | 24.3% | ||
| Q2 25 | 36.4% | 24.2% | ||
| Q1 25 | 35.2% | 25.0% | ||
| Q4 24 | 36.0% | 23.2% | ||
| Q3 24 | 35.6% | 22.6% | ||
| Q2 24 | 35.5% | 22.7% |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 13.7% | ||
| Q3 25 | 20.4% | 15.0% | ||
| Q2 25 | 20.1% | 15.0% | ||
| Q1 25 | 20.4% | 14.4% | ||
| Q4 24 | 19.8% | 13.5% | ||
| Q3 24 | 20.0% | 12.8% | ||
| Q2 24 | 19.6% | 13.2% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 10.3% | ||
| Q3 25 | 15.1% | 11.6% | ||
| Q2 25 | 15.0% | 11.6% | ||
| Q1 25 | 14.8% | 11.4% | ||
| Q4 24 | 14.0% | 10.4% | ||
| Q3 24 | 14.1% | 10.4% | ||
| Q2 24 | 13.7% | 10.2% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.47 | ||
| Q3 25 | $1.24 | $0.54 | ||
| Q2 25 | $1.17 | $0.52 | ||
| Q1 25 | $1.13 | $-1.23 | ||
| Q4 24 | $1.03 | $0.46 | ||
| Q3 24 | $1.03 | $1.35 | ||
| Q2 24 | $0.98 | $1.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $230.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $375.7M |
| Total Assets | $1.7B | $644.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $230.0M | ||
| Q3 25 | $65.1M | $207.5M | ||
| Q2 25 | $65.4M | $202.0M | ||
| Q1 25 | $49.9M | $170.6M | ||
| Q4 24 | $49.5M | $162.9M | ||
| Q3 24 | $73.7M | $138.3M | ||
| Q2 24 | $63.7M | $131.9M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $375.7M | ||
| Q3 25 | $1.3B | $362.8M | ||
| Q2 25 | $1.3B | $342.5M | ||
| Q1 25 | $1.2B | $322.0M | ||
| Q4 24 | $1.1B | $300.9M | ||
| Q3 24 | $1.2B | $282.8M | ||
| Q2 24 | $1.1B | $263.9M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $644.8M | ||
| Q3 25 | $1.7B | $611.7M | ||
| Q2 25 | $1.7B | $597.4M | ||
| Q1 25 | $1.6B | $546.0M | ||
| Q4 24 | $1.6B | $538.8M | ||
| Q3 24 | $1.6B | $518.6M | ||
| Q2 24 | $1.6B | $486.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $46.1M |
| Free Cash FlowOCF − Capex | $33.8M | $35.2M |
| FCF MarginFCF / Revenue | 12.5% | 14.9% |
| Capex IntensityCapex / Revenue | 2.3% | 4.7% |
| Cash ConversionOCF / Net Profit | 0.99× | 1.91× |
| TTM Free Cash FlowTrailing 4 quarters | — | $104.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $46.1M | ||
| Q3 25 | $65.6M | $25.0M | ||
| Q2 25 | $47.3M | $55.0M | ||
| Q1 25 | $36.5M | $22.9M | ||
| Q4 24 | $52.3M | $41.6M | ||
| Q3 24 | $51.3M | $22.3M | ||
| Q2 24 | $45.0M | $40.4M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $35.2M | ||
| Q3 25 | — | $15.3M | ||
| Q2 25 | — | $39.5M | ||
| Q1 25 | — | $14.3M | ||
| Q4 24 | — | $32.1M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $32.8M |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 14.9% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 14.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 15.5% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | 4.1% | ||
| Q2 25 | — | 6.6% | ||
| Q1 25 | — | 3.7% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | — | 3.6% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 1.91× | ||
| Q3 25 | 1.63× | 0.90× | ||
| Q2 25 | 1.23× | 2.02× | ||
| Q1 25 | 0.98× | 0.87× | ||
| Q4 24 | 1.56× | 1.75× | ||
| Q3 24 | 1.52× | 0.95× | ||
| Q2 24 | 1.40× | 1.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
Segment breakdown not available.
CRVL
| Patient Management Services | $146.1M | 62% |
| Network Solutions Services | $89.6M | 38% |
